These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Aldehyde dehydrogenase 2 (ALDH2) polymorphism gene and coronary artery disease risk: a meta-analysis. Zhang LL; Wang YQ; Fu B; Zhao SL; Kui Y Genet Mol Res; 2015 Dec; 14(4):18503-14. PubMed ID: 26782498 [TBL] [Abstract][Full Text] [Related]
43. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Healey CS; Dunning AM; Teare MD; Chase D; Parker L; Burn J; Chang-Claude J; Mannermaa A; Kataja V; Huntsman DG; Pharoah PD; Luben RN; Easton DF; Ponder BA Nat Genet; 2000 Nov; 26(3):362-4. PubMed ID: 11062481 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Moorman PG; Iversen ES; Marcom PK; Marks JR; Wang F; ; Lee E; Ursin G; Rebbeck TR; Domchek SM; Arun B; Susswein L; Isaacs C; Garber JE; Visvanathan K; Griffin CA; Sutphen R; Brzosowicz J; Gruber S; Finkelstein DM; Schildkraut JM Breast Cancer Res Treat; 2010 Nov; 124(2):441-51. PubMed ID: 20309627 [TBL] [Abstract][Full Text] [Related]
45. Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk. Serrano-Fernández P; Debniak T; Górski B; Bogdanova N; Dörk T; Cybulski C; Huzarski T; Byrski T; Gronwald J; Wokołorczyk D; Narod SA; Lubiński J Breast Cancer Res Treat; 2009 Sep; 117(1):161-5. PubMed ID: 19030985 [TBL] [Abstract][Full Text] [Related]
46. Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriers. Dick MG; Versmold B; Engel C; Meindl A; Arnold N; Varon-Mateeva R; Sutter C; Niederacher D; Deissler H; Preisler-Adams S; Kast K; Schäfer D; Gadzicki D; Heinritz W; Wappenschmidt B; Schmutzler RK Int J Cancer; 2012 Mar; 130(6):1314-8. PubMed ID: 21484799 [TBL] [Abstract][Full Text] [Related]
47. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514 [TBL] [Abstract][Full Text] [Related]
49. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055 [TBL] [Abstract][Full Text] [Related]
50. Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients. Lattimore V; Parsons MT; Spurdle AB; Pearson J; Lehnert K; Sullivan J; Lintott C; Bawden S; Morrin H; Robinson B; Walker L Breast Cancer Res Treat; 2021 Feb; 185(3):583-590. PubMed ID: 33113089 [TBL] [Abstract][Full Text] [Related]
51. DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus. Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Hadjisavvas A; Kyriacou K Breast Cancer Res Treat; 2009 Jun; 115(3):623-7. PubMed ID: 18553220 [TBL] [Abstract][Full Text] [Related]
52. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort. Freedman ML; Penney KL; Stram DO; Le Marchand L; Hirschhorn JN; Kolonel LN; Altshuler D; Henderson BE; Haiman CA Hum Mol Genet; 2004 Oct; 13(20):2431-41. PubMed ID: 15317758 [TBL] [Abstract][Full Text] [Related]
53. No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Spurdle AB; Deans AJ; Duffy D; Goldgar DE; Chen X; Beesley J; ; Easton DF; Antoniou AC; Peock S; Cook M; ; Nathanson KL; Domchek SM; MacArthur GA; Chenevix-Trench G Breast Cancer Res Treat; 2009 May; 115(2):307-13. PubMed ID: 18543099 [TBL] [Abstract][Full Text] [Related]
54. Novel and reported pathogenic variants in exon 11 of BRCA2 gene in a cohort of Sri Lankan young breast cancer patients. De Silva S; Tennekoon KH; Dissanayake A; De Silva K; Jayasekara L Fam Cancer; 2017 Jul; 16(3):329-338. PubMed ID: 28039656 [TBL] [Abstract][Full Text] [Related]
55. Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance. Surowy HM; Sutter C; Mittnacht M; Klaes R; Schaefer D; Evers C; Burgemeister AL; Goehringer C; Dikow N; Heil J; Golatta M; Schott S; Schneeweiss A; Bugert P; Sohn C; Bartram CR; Burwinkel B Breast Cancer Res Treat; 2014 Jun; 145(2):451-60. PubMed ID: 24728577 [TBL] [Abstract][Full Text] [Related]
56. The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT. Finch A; Metcalfe K; Akbari M; Friedman E; Tung N; Rosen B; Eisen A; Karlan B; Foulkes W; Neuhausen SL; Senter L; McKinnon W; Elser C; Sun P; Narod SA; Clin Genet; 2022 Mar; 101(3):317-323. PubMed ID: 34897671 [TBL] [Abstract][Full Text] [Related]
59. Lack of association of BRCA1 and BRCA2 variants with breast cancer in an ethnic population of Saudi Arabia, an emerging high-risk area. Hasan TN; Shafi G; Syed NA; Alsaif MA; Alsaif AA; Alshatwi AA Asian Pac J Cancer Prev; 2013; 14(10):5671-4. PubMed ID: 24289560 [TBL] [Abstract][Full Text] [Related]
60. ALDH2 Polymorphism and Ethanol Consumption: A Genetic-Environmental Interaction in Carcinogenesis. Yang M; Zhang Y; Ren J Adv Exp Med Biol; 2019; 1193():229-236. PubMed ID: 31368108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]